Last updated on December 2019

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC


Brief description of study

TARGET-DERM is a 5-year, longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Clinical Study Identifier: NCT03661866

Find a site near you

Start Over

Spokane Dermatology Clinic

Spokane, WA United States
6.71miles
  Connect »